Accelerate Diagnostics Inc. Stock
Heavy losses for Accelerate Diagnostics Inc. today as the stock fell by -€0.040 (-3.050%).
Pros and Cons of Accelerate Diagnostics Inc. in the next few years
Pros
?
M***** P*******
?
B****
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accelerate Diagnostics Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Accelerate Diagnostics Inc. | -3.050% | -7.299% | -21.605% | -74.600% | -64.722% | -97.460% | -99.337% |
MicroVision Inc | -1.680% | 14.428% | 25.233% | -51.092% | -60.087% | -90.020% | 89.723% |
Fonar Corp. New | -1.280% | 4.054% | 0.654% | 3.356% | -12.994% | 9.220% | -24.082% |
Allscripts Healthcare | - | 6.667% | -2.439% | -32.203% | -13.514% | -32.773% | -20.430% |
Comments
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for AXDX provided by MarketBeat
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for AXDX provided by MarketBeat